Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Seroprevalence of SARS-CoV-2 IgG antibodies, in Corsica (France), April and June 2020

View ORCID ProfileCapai Lisandru, Ayhan Nazli, Masse Shirley, Canarelli Jean, Priet Stéphane, Simeoni Marie Helene, Charrel Remi, de Lamballerie Xavier, Falchi Alessandra
doi: https://doi.org/10.1101/2020.09.29.20201368
Capai Lisandru
1UR 7310, Laboratoire de Virologie, Université de Corse, Corte, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Capai Lisandru
  • For correspondence: capai_l@univ-corse.fr falchi@univ-corse.fr
Ayhan Nazli
1UR 7310, Laboratoire de Virologie, Université de Corse, Corte, France
2Unité des Virus Émergents (UVE): Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masse Shirley
1UR 7310, Laboratoire de Virologie, Université de Corse, Corte, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Canarelli Jean
3Laboratoire de biologie médicale, CCF, Ajaccio, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Priet Stéphane
2Unité des Virus Émergents (UVE): Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simeoni Marie Helene
4Laboratoire de Biologie médicale 2A2B, 20250, Corte, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charrel Remi
2Unité des Virus Émergents (UVE): Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
de Lamballerie Xavier
2Unité des Virus Émergents (UVE): Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Falchi Alessandra
1UR 7310, Laboratoire de Virologie, Université de Corse, Corte, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: capai_l@univ-corse.fr falchi@univ-corse.fr
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Our aim was to assess the seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection after the lockdown in a sample of the Corsican population. Between 16th April and 15th June 2020, 2,312 residual sera were collected from patients having carried out a blood analysis in one of the participating laboratories. Residual sera obtained from persons of all ages were tested for the presence of anti-SARS-CoV-2 IgG using the EUROIMMUN enzyme immunoassay kit for semiquantitative detection of IgG antibodies against S1 domain of viral spike protein (ELISA-S). Borderline and positive samples in ELISA-S were also tested with an in-house virus neutralization test (VNT). Prevalence values were adjusted for sex and age. A total of 1,973 residual sera samples were included in the study. The overall seroprevalence based on ELISA-S was 5.27% [95% confidence interval (CI) 4.33-6.35] and 5.46% [4.51-6.57] after adjustment. Gender was not associated with IgG detection. However, significant differences were observed between age groups (p-value = 1 E-5) and particularly for people being younger than 50 years of age (Odd ratio (OR) = 2.86 95% CI [1.80-4.53]; p-value <0.000001*). The prevalence of neutralizing antibody titers ≥40 was of 3% [2.28-3.84]. In conclusion the present study showed that a low seroprevalence for COVID-19 in Corsica in accordance with values reported for other French regions in which the impact of the pandemic was low.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research received no external funding.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study has been declared to the CNIL (Commission nationale de l'informatique et des libertes) and the INDS (Institut National des donnees de Sante) according to the rules of the MR 004 reference method. The regulation for this type of study does not require a real authorisation but only a declaration to the institutions in accordance with the rules dictated by MR 004. University Of Corsica Pascal Paoli (IRB UCPP 2020-01) approved your study. No nominative or sensitive data on participant people have been collected. This seroprevalence study falls within the scope of the French Reference Methodology MR-004 according to 2016 41 law dated 26 January 2016 on the modernization of the French health system.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

No nominative or sensitive data on participant people have been collected. This seroprevalence study falls within the scope of the French Reference Methodology MR-004 according to 2016 41 law dated 26 January 2016 on the modernization of the French health system.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 30, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Seroprevalence of SARS-CoV-2 IgG antibodies, in Corsica (France), April and June 2020
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Seroprevalence of SARS-CoV-2 IgG antibodies, in Corsica (France), April and June 2020
Capai Lisandru, Ayhan Nazli, Masse Shirley, Canarelli Jean, Priet Stéphane, Simeoni Marie Helene, Charrel Remi, de Lamballerie Xavier, Falchi Alessandra
medRxiv 2020.09.29.20201368; doi: https://doi.org/10.1101/2020.09.29.20201368
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Seroprevalence of SARS-CoV-2 IgG antibodies, in Corsica (France), April and June 2020
Capai Lisandru, Ayhan Nazli, Masse Shirley, Canarelli Jean, Priet Stéphane, Simeoni Marie Helene, Charrel Remi, de Lamballerie Xavier, Falchi Alessandra
medRxiv 2020.09.29.20201368; doi: https://doi.org/10.1101/2020.09.29.20201368

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (49)
  • Cardiovascular Medicine (448)
  • Dentistry and Oral Medicine (80)
  • Dermatology (55)
  • Emergency Medicine (157)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (190)
  • Epidemiology (5216)
  • Forensic Medicine (3)
  • Gastroenterology (194)
  • Genetic and Genomic Medicine (750)
  • Geriatric Medicine (77)
  • Health Economics (212)
  • Health Informatics (694)
  • Health Policy (352)
  • Health Systems and Quality Improvement (223)
  • Hematology (98)
  • HIV/AIDS (162)
  • Infectious Diseases (except HIV/AIDS) (5816)
  • Intensive Care and Critical Care Medicine (356)
  • Medical Education (102)
  • Medical Ethics (25)
  • Nephrology (80)
  • Neurology (758)
  • Nursing (43)
  • Nutrition (129)
  • Obstetrics and Gynecology (141)
  • Occupational and Environmental Health (231)
  • Oncology (475)
  • Ophthalmology (149)
  • Orthopedics (38)
  • Otolaryngology (93)
  • Pain Medicine (39)
  • Palliative Medicine (19)
  • Pathology (139)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (96)
  • Psychiatry and Clinical Psychology (854)
  • Public and Global Health (1993)
  • Radiology and Imaging (344)
  • Rehabilitation Medicine and Physical Therapy (157)
  • Respiratory Medicine (283)
  • Rheumatology (93)
  • Sexual and Reproductive Health (72)
  • Sports Medicine (75)
  • Surgery (108)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)